Wealth Enhancement Advisory Services, LLC Amgen Inc Transaction History

Wealth Enhancement Advisory Services, LLC

  • $65.4 Billion
  • Q4 2025

A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Amgen Inc stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 378,221 shares of AMGN stock, worth $129 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
378,221
Previous 400,586 5.58%
Holding current value
$129 Million
Previous $113 Million 14.33%
% of portfolio
0.2%
Previous 0.18%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 08, 2026
SELL
$290.13 - $341.71 $6.49 Million - $7.64 Million
-22,365 Reduced 5.58%
378,221 $129 Million
Q3 2025

Oct 29, 2025
BUY
$271.18 - $309.22 $379,923 - $433,217
1,401 Added 0.35%
400,586 $113 Million
Q2 2025

Jul 10, 2025
BUY
$262.28 - $309.85 $3.68 Million - $4.34 Million
14,017 Added 3.64%
399,185 $111 Million
Q1 2025

Apr 16, 2025
SELL
$258.59 - $327.36 $34.6 Million - $43.7 Million
-133,628 Reduced 25.76%
385,168 $120 Million
Q4 2024

Mar 17, 2025
BUY
$258.78 - $328.31 $3.76 Million - $4.77 Million
14,516 Added 2.88%
518,796 $135 Million
Q4 2024

Jan 10, 2025
BUY
$258.78 - $328.31 $46.1 Million - $58.5 Million
178,304 Added 54.7%
504,280 $131 Million
Q3 2024

Oct 23, 2024
SELL
$309.38 - $337.38 $4.86 Million - $5.3 Million
-15,702 Reduced 4.6%
325,976 $105 Million
Q2 2024

Jul 16, 2024
BUY
$262.75 - $319.31 $3.89 Million - $4.73 Million
14,812 Added 4.53%
341,678 $107 Million
Q1 2024

Apr 15, 2024
BUY
$268.87 - $324.56 $5.12 Million - $6.18 Million
19,029 Added 6.18%
326,866 $92.9 Million
Q4 2023

Jan 30, 2024
BUY
$255.7 - $288.46 $2.59 Million - $2.93 Million
10,146 Added 3.41%
307,837 $88.7 Million
Q3 2023

Nov 13, 2023
BUY
$218.65 - $271.46 $64.7 Million - $80.4 Million
296,057 Added 18118.54%
297,691 $80 Million
Q2 2023

Jul 21, 2023
SELL
$214.27 - $253.37 $5.16 Million - $6.1 Million
-24,079 Reduced 93.65%
1,634 $362,000
Q1 2023

Apr 25, 2023
BUY
$225.79 - $275.2 $5.62 Million - $6.85 Million
24,888 Added 3016.73%
25,713 $6.22 Million
Q4 2022

Feb 01, 2023
BUY
$229.03 - $291.01 $188,949 - $240,083
825 New
825 $216,000
Q2 2022

Jul 18, 2022
BUY
$230.71 - $256.74 $12.3 Million - $13.7 Million
53,352 Added 6254.63%
54,205 $13.5 Million
Q1 2022

Apr 18, 2022
BUY
$219.27 - $242.57 $187,037 - $206,912
853 New
853 $209,000
Q2 2021

Aug 10, 2021
SELL
$233.58 - $259.14 $3.98 Million - $4.41 Million
-17,023 Closed
0 $0
Q1 2021

May 12, 2021
BUY
$221.91 - $258.6 $113,396 - $132,144
511 Added 3.09%
17,023 $4.24 Million
Q4 2020

Feb 10, 2021
BUY
$216.38 - $257.67 $3.57 Million - $4.25 Million
16,512 New
16,512 $4.05 Million
Q1 2020

May 01, 2020
SELL
$182.24 - $241.7 $3.63 Million - $4.82 Million
-19,937 Closed
0 $0
Q4 2019

Feb 05, 2020
BUY
$189.21 - $243.2 $947,752 - $1.22 Million
5,009 Added 33.55%
19,937 $4.81 Million
Q3 2019

Nov 06, 2019
BUY
$174.11 - $208.62 $2.6 Million - $3.11 Million
14,928 New
14,928 $3 Million
Q2 2019

Aug 02, 2019
SELL
$166.7 - $195.41 $1.32 Million - $1.54 Million
-7,893 Closed
0 $0
Q1 2019

Apr 30, 2019
SELL
$180.87 - $203.88 $1.43 Million - $1.61 Million
-7,915 Reduced 50.07%
7,893 $1.42 Million
Q4 2018

Feb 04, 2019
SELL
$178.4 - $208.25 $348,058 - $406,295
-1,951 Reduced 10.99%
15,808 $3.22 Million
Q3 2018

Nov 02, 2018
BUY
$185.29 - $208.89 $3.29 Million - $3.71 Million
17,759 New
17,759 $3.34 Million
Q4 2017

Jan 19, 2018
SELL
$168.79 - $188.59 $873,825 - $976,330
-5,177 Closed
0 $0
Q3 2017

Oct 18, 2017
BUY
$167.29 - $191.0 $866,060 - $988,807
5,177
5,177 $962,000

Others Institutions Holding AMGN

# of Institutions
3,342
Shares Held
428M
Call Options Held
6.11M
Put Options Held
5.85M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $183B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Wealth Enhancement Advisory Services, LLC Portfolio

Follow Wealth Enhancement Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Enhancement Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Enhancement Advisory Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email